| Reference |
|---|
Eernstman J, Veldhuisen B, Ligthart P, von Lindern M, van der Schoot C, van den Akker E. Novel variants in Krueppel like factor 1 that cause persistence of fetal hemoglobin in In(Lu) individuals. Sci Rep. 2021;11:18557 pubmed publisher |
Thornton N, Karamatic Crew V, Tilley L, Green C, Tay C, Griffiths R, et al. Disruption of the tumour-associated EMP3 enhances erythroid proliferation and causes the MAM-negative phenotype. Nat Commun. 2020;11:3569 pubmed publisher |
Thomé C, Ferreira G, Pereira Martins D, Dos Santos G, Ortiz C, de Souza L, et al. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Sci Rep. 2020;10:10315 pubmed publisher |
Xu R, Li X, Boreland A, Posyton A, Kwan K, Hart R, et al. Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain. Nat Commun. 2020;11:1577 pubmed publisher |
Xu Y, Man N, Karl D, Martínez C, Liu F, Sun J, et al. TAF1 plays a critical role in AML1-ETO driven leukemogenesis. Nat Commun. 2019;10:4925 pubmed publisher |
Song L, Yuan X, Jones Z, Vied C, Miao Y, Marzano M, et al. Functionalization of Brain Region-specific Spheroids with Isogenic Microglia-like Cells. Sci Rep. 2019;9:11055 pubmed publisher |
Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed publisher |
Trump L, Nayak R, Singh A, Emberesh S, Wellendorf A, LUTZKO C, et al. Neutrophils Derived from Genetically Modified Human Induced Pluripotent Stem Cells Circulate and Phagocytose Bacteria In Vivo. Stem Cells Transl Med. 2019;8:557-567 pubmed publisher |
Fekete T, Bencze D, Szabo A, Csoma E, Biro T, Bacsi A, et al. Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells. Front Immunol. 2018;9:2314 pubmed publisher |
Rio P, Navarro S, Guenechea G, Sánchez Domínguez R, Lamana M, Yañez R, et al. Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients. Blood. 2017;130:1535-1542 pubmed publisher |
Morris E, Fox T, Chakraverty R, Tendeiro R, Snell K, Rivat C, et al. Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult. Blood. 2017;130:1327-1335 pubmed publisher |
Kapp K, Schneider J, Schneider L, Gollinge N, J xe4 nsch S, Schroff M, et al. Distinct immunological activation profiles of dSLIM® and ProMune® depend on their different structural context. Immun Inflamm Dis. 2016;4:446-462 pubmed |
Wen W, Zhang J, Xu J, Su R, Neises A, Ji G, et al. Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors. Stem Cell Reports. 2016;6:873-884 pubmed publisher |
Churko J, Burridge P, Wu J. Generation of human iPSCs from human peripheral blood mononuclear cells using non-integrative Sendai virus in chemically defined conditions. Methods Mol Biol. 2013;1036:81-8 pubmed publisher |
Szabo A, Gogolak P, Pazmandi K, Kis Toth K, Riedl K, Wizel B, et al. The two-component adjuvant IC31® boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs. PLoS ONE. 2013;8:e55264 pubmed publisher |
Klco J, Spencer D, Lamprecht T, Sarkaria S, Wylie T, Magrini V, et al. Genomic impact of transient low-dose decitabine treatment on primary AML cells. Blood. 2013;121:1633-43 pubmed publisher |
Nakajima Takagi Y, Osawa M, Oshima M, Takagi H, Miyagi S, Endoh M, et al. Role of SOX17 in hematopoietic development from human embryonic stem cells. Blood. 2013;121:447-58 pubmed publisher |
Yamagata Y, Parietti V, Stockholm D, Corre G, Poinsignon C, Touleimat N, et al. Lentiviral transduction of CD34(+) cells induces genome-wide epigenetic modifications. PLoS ONE. 2012;7:e48943 pubmed publisher |
Li X, Ha C, Fu D, Xiao M. Micro-RNA30c negatively regulates REDD1 expression in human hematopoietic and osteoblast cells after gamma-irradiation. PLoS ONE. 2012;7:e48700 pubmed publisher |
Mizrahi K, Stein J, Yaniv I, Kaplan O, Askenasy N. TNF-? has tropic rather than apoptotic activity in human hematopoietic progenitors: involvement of TNF receptor-1 and caspase-8. Stem Cells. 2013;31:156-66 pubmed publisher |
Roy A, Cowan G, Mead A, Filippi S, Bohn G, Chaidos A, et al. Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci U S A. 2012;109:17579-84 pubmed publisher |
Thiollier C, Lopez C, Gerby B, Ignacimouttou C, Poglio S, Duffourd Y, et al. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models. J Exp Med. 2012;209:2017-31 pubmed publisher |
Shi B, Ren G, Hu Y, Wang S, Zhang Z, Yuan Z. HBsAg inhibits IFN-? production in plasmacytoid dendritic cells through TNF-? and IL-10 induction in monocytes. PLoS ONE. 2012;7:e44900 pubmed |
Yang T, Jian W, Luo Y, Fu X, NOGUCHI C, Bungert J, et al. Acetylation of histone deacetylase 1 regulates NuRD corepressor complex activity. J Biol Chem. 2012;287:40279-91 pubmed publisher |
Vatolin S, Khan S, Reu F. Direct chromatin PCR (DC-PCR): hypotonic conditions allow differentiation of chromatin states during thermal cycling. PLoS ONE. 2012;7:e44690 pubmed publisher |
Williams A, Li L, Nguyen B, Brown P, Levis M, Small D. Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia. Blood. 2012;120:3069-79 pubmed publisher |
Gori J, Chandrasekaran D, Kowalski J, Adair J, Beard B, D Souza S, et al. Efficient generation, purification, and expansion of CD34(+) hematopoietic progenitor cells from nonhuman primate-induced pluripotent stem cells. Blood. 2012;120:e35-44 pubmed |
Baba Y, Maeda K, Yashiro T, Inage E, Kasakura K, Suzuki R, et al. GATA2 is a critical transactivator for the human IL1RL1/ST2 promoter in mast cells/basophils: opposing roles for GATA2 and GATA1 in human IL1RL1/ST2 gene expression. J Biol Chem. 2012;287:32689-96 pubmed |
Skavland J, Jørgensen K, Hadziavdic K, Hovland R, Jonassen I, Bruserud O, et al. Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia. Blood Cancer J. 2011;1:e4 pubmed publisher |
Gao H, Wu X, Sun Y, Zhou S, Silberstein L, Zhu Z. Suppression of homeobox transcription factor VentX promotes expansion of human hematopoietic stem/multipotent progenitor cells. J Biol Chem. 2012;287:29979-87 pubmed publisher |
Skrzeczyńska Moncznik J, Wlodarczyk A, Zabieglo K, Kapinska Mrowiecka M, Marewicz E, Dubin A, et al. Secretory leukocyte proteinase inhibitor-competent DNA deposits are potent stimulators of plasmacytoid dendritic cells: implication for psoriasis. J Immunol. 2012;189:1611-7 pubmed publisher |
Will B, Zhou L, Vogler T, Ben Neriah S, Schinke C, Tamari R, et al. Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. Blood. 2012;120:2076-86 pubmed publisher |
Aggarwal R, Lu J, Kanji S, Joseph M, Das M, Noble G, et al. Human umbilical cord blood-derived CD34+ cells reverse osteoporosis in NOD/SCID mice by altering osteoblastic and osteoclastic activities. PLoS ONE. 2012;7:e39365 pubmed publisher |
Ramos Mejia V, Montes R, Bueno C, Ayllon V, Real P, Rodriguez R, et al. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. PLoS ONE. 2012;7:e35824 pubmed publisher |
Scaramuzza S, Biasco L, Ripamonti A, Castiello M, Loperfido M, Draghici E, et al. Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome. Mol Ther. 2013;21:175-84 pubmed publisher |
Kalb M, Glaser A, Stary G, Koszik F, Stingl G. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-?-mediated antitumor reactivity. J Immunol. 2012;188:1583-91 pubmed publisher |
Punzo F, Bertoli Avella A, Scianguetta S, Della Ragione F, Casale M, Ronzoni L, et al. Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene. Orphanet J Rare Dis. 2011;6:89 pubmed publisher |
Rådinger M, Smrž D, Metcalfe D, Gilfillan A. Glycogen synthase kinase-3β is a prosurvival signal for the maintenance of human mast cell homeostasis. J Immunol. 2011;187:5587-95 pubmed publisher |
Chen H, Sun H, You F, Sun W, Zhou X, Chen L, et al. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell. 2011;147:436-46 pubmed publisher |
Grebien F, Hantschel O, Wojcik J, Kaupe I, Kovacic B, Wyrzucki A, et al. Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis. Cell. 2011;147:306-19 pubmed publisher |
Sarma N, Yaseen N. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability. J Biol Chem. 2011;286:38989-9001 pubmed publisher |
Mali R, Ramdas B, Ma P, Shi J, Munugalavadla V, Sims E, et al. Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL. Cancer Cell. 2011;20:357-69 pubmed publisher |
Zhou J, Bi C, Cheong L, Mahara S, Liu S, Tay K, et al. The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML. Blood. 2011;118:2830-9 pubmed publisher |
Sheng Z, Ma L, Sun J, Zhu L, Green M. BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription. Blood. 2011;118:2840-8 pubmed publisher |
Matthes T, Dunand Sauthier I, Santiago Raber M, Krause K, Donze O, Passweg J, et al. Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow. Blood. 2011;118:1838-44 pubmed publisher |
